How much has Convergent Therapeutics raised?
$130.0Macross 2 recorded rounds · May 2023 – Jul 2024
Most recently, Convergent Therapeutics raised $22.2M in its Early Stage VC (Jul 2024).
Free account
More of Convergent Therapeutics with a free account
- ·Watch Convergent Therapeutics: the Monday email on marks, rounds and moves
Convergent Therapeutics round by round
2 rounds1 investors participated
May 2023Early Stage VC (Series A)$90.0M▮
+ 1 more investors · free account
How much has Convergent Therapeutics raised?
Convergent Therapeutics has raised $130 million across 2 recorded rounds since 2023. The largest was a $90 million Series A in May 2023; the most recent was a $22.2 million early-stage round in Jul 2024.
Convergent Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently in Aug 2024 ($22.2 million sold to 1 investor).
Convergent Therapeutics investors
4 investors are on record for Convergent Therapeutics, including RA Capital Management, OrbiMed, Novo Holdings and The Invus Group. The early-stage round in Jul 2024 drew 1 investor.
For fundraisers
Raising for a company like Convergent Therapeutics?
4 investors have backed Convergent Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Convergent Therapeutics
- How much has Convergent Therapeutics raised?
- Convergent Therapeutics has raised $130.0M in total across 2 recorded funding rounds.
- When was Convergent Therapeutics's last funding round?
- Convergent Therapeutics's most recent recorded round was Early Stage VC in Jul 2024, raising $22.2M.